Related Experiment Videos
Ketoconazole: a possible direct cytotoxic effect on prostate carcinoma cells
T Eichenberger1, J Trachtenberg, P Toor
1Division of Urology, Toronto General Hospital, Ontario, Canada.
The Journal of Urology
|January 1, 1989
Summary
Ketoconazole significantly inhibits prostate cancer cell growth. Clinically relevant doses suppressed tumor colony formation by over 90% in hormone-independent cell lines, suggesting a direct cytotoxic effect.
Area of Science:
- Oncology
- Pharmacology
Background:
- Ketoconazole is used for advanced prostate cancer, primarily for inhibiting androgen production.
- The direct cytotoxic effects of ketoconazole on prostate cancer cells are not fully understood.
Purpose of the Study:
- To investigate the direct cytotoxic impact of ketoconazole on human hormone-independent prostate cancer cell lines.
- To determine if ketoconazole affects prostate cancer cell viability beyond androgen suppression.
Main Methods:
- Utilized an in vitro clonogenic tumor assay.
- Studied the effects of ketoconazole on human prostate cancer cell lines (PC-3 and DU-145).
Main Results:
- Ketoconazole demonstrated significant cytotoxic effects on prostate cancer cells.
- Clinically achievable doses of ketoconazole led to over 90% suppression of tumor colony growth.
- The drug exhibits direct anti-proliferative activity against hormone-independent prostate cancer cells.
Conclusions:
- Ketoconazole possesses a direct cytotoxic effect on prostate cancer cells.
- This direct action may contribute to its efficacy in treating advanced prostate cancer.
- Further research into ketoconazole's direct anti-cancer mechanisms is warranted.